OrganoBiotech
PrivateCompany Overview
OrganoBiotech is a biotechnology company that develops organ-on-a-chip platform technologies and automated 3D tissue models to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganoBiotech Comparables
Compare OrganoBiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIM Biotech | 87% | |
| BiomimX | 87% | |
| AlveoliX AG | 86% |
OrganoBiotech Funding Rounds
Historical fundraising activity
OrganoBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Stem Cell Network | Grant |
| Canada Foundation for Innovation | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| McMaster University | Grant |
OrganoBiotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OrganoBiotech's valuation, stock price, and market status.
Is OrganoBiotech a public or private company?
OrganoBiotech is a private company.
What is the current stock price of OrganoBiotech?
OrganoBiotech is a private company with no public stock price. No recent secondary market data is available.
How much is OrganoBiotech worth (valuation)?
Valuation information for OrganoBiotech is not publicly available.
Can I buy OrganoBiotech stock?
OrganoBiotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OrganoBiotech's last funding round?
Funding round information for OrganoBiotech is not publicly available.
Who are the main investors in OrganoBiotech?
Key investors in OrganoBiotech include Canadian Institutes of Health Research, Stem Cell Network, Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, McMaster University.
Will OrganoBiotech IPO soon?
No public IPO plans have been announced for OrganoBiotech.
How can I track OrganoBiotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrganoBiotech's secondary market activity and sign up for updates.